No 02 2025

Elypta has announced its role as a main partner in PREDI-LYNCH, a European initiative aimed at transforming early cancer detection for individuals with Lynch Syndrome (LS).

One of the most compelling trends in the life science sector today is the evolving role of data in decision-making processes. Life science companies are harnessing big data in ways that were once unimaginable, driven by technological advancements like AI, machine learning, and digital transformation. But as we look beyond 2025, it’s crucial to ask: How can these vast data resources be used to create actionable insights that lead to real-world impact? 

As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk.

The two companies have announced an exclusive global collaboration and license agreement to discover, develop and commercialize oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.

Emma Ryan Lind is the Head of Marketing and Products at Atlas Antibodies. She explains what it means to lead marketing in a biotechnology company and the challenges that come with the job.

The collaboration will complement PeptiSystems’ flow-based instrumentation systems with Asahi Kasei Bioprocess America (AKBA)’s column technology.

NorthX Biologics has announced an investment from Signet Healthcare Partners, a US-based healthcare private equity firm with expertise in pharmaceutical services.